|
|
||||||||||
|
J Am Coll Cardiol, 1999; 33:661-669 © 1999 by the American College of Cardiology Foundation |



























* Division of Cardiology, Emory University, Atlanta, Georgia, USA
New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York, USA
Cedars-Sinai Medical Center, Los Angeles, California; USA
Cleveland Clinic Foundation, Cleveland, Ohio, USA
|| Hartford Hospital, Hartford, Connecticut, USA
¶ Duke University Medical Center, Durham, North Carolina, USA
# Roger Williams Hospital, Providence, Rhode Island, USA
** Northwestern University, Chicago, Illinois, USA

Saint Louis University, Saint Louis, Missouri, USA

Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA
Manuscript received October 14, 1997; revised manuscript received September 28, 1998, accepted November 5, 1998.
Reprint requests and correspondence: Dr. Leslee J. Shaw, Division of Cardiology, Room 638, 1518 Clifton Road, Rollins School of Public Health, Emory University, Atlanta, Georgia 30303
OBJECTIVES
The study aim was to determine observational differences in costs of care by the coronary disease diagnostic test modality.
BACKGROUND
A number of diagnostic strategies are available with few data to compare the cost implications of the initial test choice.
METHODS
We prospectively enrolled 11,372 consecutive stable angina patients who were referred for stress myocardial perfusion tomography or cardiac catheterization. Stress imaging patients were matched by their pretest clinical risk of coronary disease to a series of patients referred to cardiac catheterization. Composite 3-year costs of care were compared for two patients management strategies: 1) direct cardiac catheterization (aggressive) and 2) initial stress myocardial perfusion tomography and selective catheterization of high risk patients (conservative). Analysis of variance techniques were used to compare costs, adjusting for treatment propensity and pretest risk.
RESULTS
Observational comparisons of aggressive as compared with conservative testing strategies reveal that costs of care were higher for direct cardiac catheterization in all clinical risk subsets (range: $2,878 to $4,579), as compared with stress myocardial perfusion imaging plus selective catheterization (range: $2,387 to $3,010, p < 0.0001). Coronary revascularization rates were higher for low, intermediate and high risk direct catheterization patients as compared with the initial stress perfusion imaging cohort (13% to 50%, p < 0.0001); cardiac death or myocardial infarction rates were similar (p > 0.20).
CONCLUSIONS
Observational assessments reveal that stable chest pain patients who undergo a more aggressive diagnostic strategy have higher diagnostic costs and greater rates of intervention and follow-up costs. Cost differences may reflect a diminished necessity for resource consumption for patients with normal test results.
This article has been cited by other articles:
![]() |
L. J. Shaw, D. S. Berman, D. J. Maron, G. B. J. Mancini, S. W. Hayes, P. M. Hartigan, W. S. Weintraub, R. A. O'Rourke, M. Dada, J. A. Spertus, et al. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy Circulation, March 11, 2008; 117(10): 1283 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Marcassa, J. J. Bax, F. Bengel, B. Hesse, C. L. Petersen, E. Reyes, R. Underwood, and on behalf of the European Council of Nuclear Cardi Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement Eur. Heart J., February 2, 2008; 29(4): 557 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schwitter, C. M. Wacker, A. C. van Rossum, M. Lombardi, N. Al-Saadi, H. Ahlstrom, T. Dill, H. B.W. Larsson, S. D. Flamm, M. Marquardt, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial Eur. Heart J., February 2, 2008; 29(4): 480 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hernandez and L. Vale The Value of Myocardial Perfusion Scintigraphy in the Diagnosis and Management of Angina and Myocardial Infarction: A Probabilistic Economic Analysis Med Decis Making, December 1, 2007; 27(6): 772 - 788. [Abstract] [PDF] |
||||
![]() |
J. J. Mahmarian Computed Tomography Coronary Angiography as an Anatomic Basis for Risk Stratification: Deja Vu or Something New? J. Am. Coll. Cardiol., September 18, 2007; 50(12): 1171 - 1173. [Full Text] [PDF] |
||||
![]() |
M. E. Merhige, W. J. Breen, V. Shelton, T. Houston, B. J. D'Arcy, and A. F. Perna Impact of Myocardial Perfusion Imaging with PET and 82Rb on Downstream Invasive Procedure Utilization, Costs, and Outcomes in Coronary Disease Management J. Nucl. Med., July 1, 2007; 48(7): 1069 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Di Carli, S. Dorbala, J. Meserve, G. El Fakhri, A. Sitek, and S. C. Moore Clinical Myocardial Perfusion PET/CT J. Nucl. Med., May 1, 2007; 48(5): 783 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Di Carli and R. Hachamovitch New Technology for Noninvasive Evaluation of Coronary Artery Disease Circulation, March 20, 2007; 115(11): 1464 - 1480. [Full Text] [PDF] |
||||
![]() |
S. Dorbala, R. Hachamovitch, and M. F. Di Carli Myocardial Perfusion Imaging and Multidetector Computed Tomographic Coronary Angiography: Appropriate for All Patients With Suspected Coronary Artery Disease? J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2515 - 2517. [Full Text] [PDF] |
||||
![]() |
J. J. Mahmarian, L. J. Shaw, N. G. Filipchuk, H. A. Dakik, S. S. Iskander, T. D. Ruddy, M. J. Henzlova, F. Keng, A. Allam, L. A. Moye, et al. A Multinational Study to Establish the Value of Early Adenosine Technetium-99m Sestamibi Myocardial Perfusion Imaging in Identifying a Low-Risk Group for Early Hospital Discharge After Acute Myocardial Infarction J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2448 - 2457. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Shaw, T. H. Marwick, D. S. Berman, S. Sawada, G. V. Heller, C. Vasey, and D. D. Miller Incremental cost-effectiveness of exercise echocardiography vs. SPECT imaging for the evaluation of stable chest pain Eur. Heart J., October 2, 2006; 27(20): 2448 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Di Carli CT Coronary Angiography: Where Does It Fit? J. Nucl. Med., September 1, 2006; 47(9): 1397 - 1399. [Full Text] [PDF] |
||||
![]() |
E. Reyes and S. R. Underwood Myocardial perfusion scintigraphy: an important step between clinical assessment and coronary angiography in patients with stable chest pain Eur. Heart J., January 1, 2006; 27(1): 3 - 4. [Full Text] [PDF] |
||||
![]() |
P. F. Hoilund-Carlsen, A. Johansen, H. W. Christensen, W. Vach, M. Moldrup, P. Bartram, A. Veje, T. Haghfelt, and for the Myocardial Ischemia Logistics Evaluation S Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris: observational study without post-test referral bias Eur. Heart J., January 1, 2006; 27(1): 29 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
Prepared jointly by the British Cardiac Society, t Setting up a myocardial perfusion scintigraphy service: clinical and business aspects Heart, September 1, 2005; 91(suppl_4): iv6 - iv14. [Full Text] [PDF] |
||||
![]() |
R. Hachamovitch and M. F. Di Carli Are Human Readers Needed for Prognostication from Stress Myocardial Perfusion SPECT? Using Outcomes Research to Validate Medical Technology J. Nucl. Med., February 1, 2005; 46(2): 194 - 197. [Full Text] [PDF] |
||||
![]() |
A. Abidov, R. Hachamovitch, A. Rozanski, S. W. Hayes, M. M. Santos, M. G. Sciammarella, I. Cohen, J. Gerlach, J. D. Friedman, G. Germano, et al. Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1062 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
T M Bateman and E Prvulovich Assessment of prognosis in chronic coronary artery disease Heart, August 1, 2004; 90(suppl_5): v10 - v15. [Full Text] [PDF] |
||||
![]() |
S R Underwood and L J Shaw Myocardial perfusion scintigraphy and cost effectiveness of diagnosis and management of coronary heart disease Heart, August 1, 2004; 90(suppl_5): v34 - v36. [Full Text] [PDF] |
||||
![]() |
S L Rahman and A D Kelion Nuclear cardiology in the UK: do we apply evidence based medicine? Heart, August 1, 2004; 90(suppl_5): v37 - v40. [Full Text] [PDF] |
||||
![]() |
B. D. Johnson, L. J. Shaw, S. D. Buchthal, C. N. Bairey Merz, H.-W. Kim, K. N. Scott, M. Doyle, M. B. Olson, C. J. Pepine, J. den Hollander, et al. Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease: Results From the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Circulation, June 22, 2004; 109(24): 2993 - 2999. [Abstract] [Full Text] [PDF] |
||||
![]() |
N K Sabharwal and A Lahiri Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease Heart, November 1, 2003; 89(11): 1291 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-S. Yao, E. Qureshi, M. V. Sherrid, and F. A. Chaudhry Practical applications in stress echocardiography: Risk stratification and prognosis in patientswith known or suspected ischemic heart disease J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1084 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Schwartz, T. A. Pearson, V. G. Kalaria, M. L. Mackin, D. J. Williford, A. Awasthi, A. Shah, A. Rains, and J. J. Guido Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: Coronary artery disease regression single photon emission computed tomography monitoring trial J. Am. Coll. Cardiol., August 20, 2003; 42(4): 600 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.H. Marwick, L. Shaw, C. Case, C. Vasey, and J.D. Thomas Clinical and economic impact of exercise electrocardiography and exercise echocardiography in clinical practice Eur. Heart J., June 2, 2003; 24(12): 1153 - 1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hachamovitch, S. Hayes, J. D. Friedman, I. Cohen, L. J. Shaw, G. Germano, and D. S. Berman Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1329 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Shaw, R. Hendel, S. Borges-Neto, M. S. Lauer, N. Alazraki, J. Burnette, E. Krawczynska, M. Cerqueira, and J. Maddahi Prognostic Value of Normal Exercise and Adenosine 99mTc-Tetrofosmin SPECT Imaging: Results from the Multicenter Registry of 4,728 Patients J. Nucl. Med., February 1, 2003; 44(2): 134 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Anderson, L. Littmann, R. Hachamovitch, D. S. Berman, H. Kiat, I. Cohen, J. D. Friedman, and L. J. Shaw Stress Single Photon Emission Computed Tomography in Patients With Normal Electrocardiograms * Response Circulation, October 8, 2002; 106 (15): e71 - e72. [Full Text] [PDF] |
||||
![]() |
S. Giri, L. J. Shaw, D. R. Murthy, M. I. Travin, D. D. Miller, R. Hachamovitch, S. Borges-Neto, D. S. Berman, D. D. Waters, and G. V. Heller Impact of Diabetes on the Risk Stratification Using Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging in Patients With Symptoms Suggestive of Coronary Artery Disease Circulation, January 1, 2002; 105(1): 32 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Ohman and E. Peterson Implications and Challenges Using Practice Guidelines for Chronic Angina Ann Intern Med, October 2, 2001; 135(7): 527 - 529. [Full Text] [PDF] |
||||
![]() |
L. J. Shaw, A. E. Iskandrian, R. Hachamovitch, G. Germano, H. C. Lewin, T. M. Bateman, and D. S. Berman Evidence-Based Risk Assessment in Noninvasive Imaging J. Nucl. Med., September 1, 2001; 42(9): 1424 - 1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.J. Shaw, D.S. Berman, and D.D. Miller Cost-effectiveness of myocardial perfusion imaging in the evaluation of patients with known or suspected coronary artery disease Eur. Heart J. Suppl., September 1, 2001; 3(suppl_F): F15 - F18. [Abstract] [PDF] |
||||
![]() |
J I Davar, E B Roberts, J G Coghlan, T R Evans, and D P Lipkin Prognostic value of stress echocardiography in women with high ({>=}80%) probability of coronary artery disease Postgrad. Med. J., September 1, 2001; 77(911): 573 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Mast, L. K. Shaw, G. C. Ravizzini, M. Chambless, P. Joski, R. E. Coleman, and S. Borges-Neto Incremental Prognostic Value of RNA Ejection Fraction Measurements During Pharmacologic Stress Testing: A Comparison with Clinical and Perfusion Variables J. Nucl. Med., June 1, 2001; 42(6): 871 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Marwick, C. Case, C. Vasey, S. Allen, L. Short, and J. D. Thomas Prediction of Mortality by Exercise Echocardiography : A Strategy for Combination With the Duke Treadmill Score Circulation, May 29, 2001; 103(21): 2566 - 2571. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Marwick, C. Case, S. Sawada, C. Rimmerman, P. Brenneman, R. Kovacs, L. Short, and M. Lauer Prediction of mortality using dobutamine echocardiography J. Am. Coll. Cardiol., March 1, 2001; 37(3): 754 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Beller Perfusion imaging J. Am. Coll. Cardiol., April 1, 2000; 35(5_Suppl_B): 29B - 31B. [PDF] |
||||
![]() |
G. A. Beller and B. L. Zaret Contributions of Nuclear Cardiology to Diagnosis and Prognosis of Patients With Coronary Artery Disease Circulation, March 28, 2000; 101(12): 1465 - 1478. [Full Text] [PDF] |
||||
![]() |
R. Hachamovitch, D. S. Berman, H. Kiat, I. Cohen, J. D. Friedman, and L. J. Shaw Value of Stress Myocardial Perfusion Single Photon Emission Computed Tomography in Patients With Normal Resting Electrocardiograms: An Evaluation of Incremental Prognostic Value and Cost-Effectiveness Circulation, February 19, 2002; 105(7): 823 - 829. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |